Overview: Medical Comorbidities and ASD
In this brief overview, neurologist Margaret Bauman, MD summarizes symptoms and signs of medical comorbidities that frequently occur, but may go unrecognized, in patients diagnosed with ASD. While the
Webinars provided in partnership with:
ARI’s free autism research and treatment webinars for people with autism, parents, physicians, and other professionals are made possible by generous donor support.
In this brief overview, neurologist Margaret Bauman, MD summarizes symptoms and signs of medical comorbidities that frequently occur, but may go unrecognized, in patients diagnosed with ASD. While the
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by impaired social interaction, delayed and disordered communication skills and isolated areas of interest. There
Catatonia and disruptive mood regulation disorder (DMDD) are increasingly recognized as co-occurring conditions associated with autism spectrum disorders. Learn about recognition and treatment
Learn about emerging research on the effectiveness of cannabidivarin (CBDV) on irritability and repetitive behaviors in children with ASD. CBDV is a non-psychoactive chemical
Tune in as David Amaral, Ph.D., presents on advances in brain tissue donation and research. This presentation is on YouTube and can be shared on social media,
¿Qué deberían hacer los padres y cuidadores si sospechan que su hijo puede tener un trastorno del espectro autista (TEA)? ¿Qué deberían considerar una vez que un
Dr. Edward Quadros serves as a research professor in the Department of Medicine at SUNY Downstate Medical Center. Research in
For more than 20 years, researchers have been studying TMS as a potential therapy for a number of neurological and
Current evidence points to an increase in inflammation markers and oxidative stress in individuals with ASD. Hear Andrew Zimmerman, MD discuss changes in the brain associated with
Theoharis Theoharides, MD, Ph.D. is a professor of pharmacology, Internal Medicine and Biochemistry, and the director of the Laboratory of Molecular Immunopharmacology and Drug Discovery; Department of